# Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles

> **NCT05520125** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus** · enrollment: 20 (estimated)

## Conditions studied

- Segmental Fracture - Bone Loss

## Interventions

- **BIOLOGICAL:** Mesenchymal stem cells enriched by extracellular vesicles
- **OTHER:** Standard treatment of bone defects

## Key facts

- **NCT ID:** NCT05520125
- **Lead sponsor:** Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05520125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05520125, "Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05520125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*